Inozyme Pharma
Boston, US · Founded 2015 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
AB
Axel BolteExecutive Officer, Director
EM
Edward MathersDirector
RD
Reinaldo DiazDirector
RH
Rob HopfnerDirector
ME
Martin EdwardsDirector
JS
Joseph SchlessingerExecutive Officer, Director
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$67.4MraisedJun 2020 · 12 investors · PharmaceuticalsRule 506(b)
▶$67.4MraisedJun 2020 · 12 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Sarah BhagatDirector
- Lynne SullivanDirector
- Reinaldo DiazDirector
- Rob HopfnerDirector
- Edward MathersDirector
- Martin EdwardsDirector
- Axel BolteExecutive Officer, Director
- Douglas TrecoDirector
- Offering amount
- $67.4M
- Amount sold
- $67.4M
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$48.9MraisedNov 2018 · 14 investors · PharmaceuticalsRule 506(b)
▶$48.9MraisedNov 2018 · 14 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Axel BolteExecutive Officer, Director
- Edward MathersDirector
- Reinaldo DiazDirector
- Rob HopfnerDirector
- Martin EdwardsDirector
- Joseph SchlessingerExecutive Officer, Director
- Offering amount
- $48.9M
- Amount sold
- $48.9M
- First sale
- Jan 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.